Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.590
+0.250 (18.66%)
Aug 5, 2026, 12:33 PM EDT - Market open

Geron Revenue

Geron had revenue of $51.84M in the quarter ending March 31, 2026, with 30.89% growth. This brings the company's revenue in the last twelve months to $196.12M, up 68.64% year-over-year. In the year 2025, Geron had annual revenue of $183.88M with 138.83% growth.

Revenue (ttm)
$196.12M
Revenue Growth
+68.64%
P/S Ratio
4.97
Revenue / Employee
$792,864
Employees
258
Market Cap
1.02B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025183.88M106.89M138.83%
Dec 31, 202476.99M76.76M32,386.92%
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 20181.07M1,000.000.09%
Dec 31, 20171.07M-5.10M-82.72%
Dec 31, 20166.16M-30.21M-83.06%
Dec 31, 201536.37M35.22M3,054.47%
Dec 31, 20141.15M-130.00K-10.13%
Dec 31, 20131.28M-1.43M-52.64%
Dec 31, 20122.71M271.00K11.12%
Dec 31, 20112.44M-1.13M-31.57%
Dec 31, 20103.56M1.84M106.43%
Dec 31, 20091.73M-1.08M-38.42%
Dec 31, 20082.80M-4.82M-63.22%
Dec 31, 20077.62M4.35M132.59%
Dec 31, 20063.28M-2.88M-46.78%
Dec 31, 20056.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arbutus Biopharma191.45M
Theravance Biopharma109.78M
Kura Oncology71.64M
Omeros9.89M
Aclaris Therapeutics8.37M
Revenue Rankings